|
|
|
|
LEADER |
00000cam a2200000Ii 4500 |
001 |
SCIDIR_ocn963966289 |
003 |
OCoLC |
005 |
20231120112155.0 |
006 |
m o d |
007 |
cr cnu---unuuu |
008 |
161122t20172017enka ob 000 0 eng d |
040 |
|
|
|a OPELS
|b eng
|e rda
|e pn
|c OPELS
|d OCLCQ
|d VZR
|d OCLCO
|d VZR
|d OCLCO
|d OCLCQ
|d OTZ
|d USU
|d MMU
|d BUF
|d CASUM
|d UIU
|d OCLCO
|d N$T
|d LEATE
|d OCLCA
|d MERER
|d OCLCQ
|d U3W
|d OCLCF
|d OCLCO
|d OCLCQ
|d UHL
|d OCLCO
|d NLW
|d OCLCA
|d OCLCQ
|d OCLCO
|d OPELS
|d OCLCO
|d OCLCQ
|d OCLCO
|
019 |
|
|
|a 1118352612
|a 1274730032
|a 1300507751
|
020 |
|
|
|a 9780128030356
|q (electronic bk.)
|
020 |
|
|
|a 0128030356
|q (electronic bk.)
|
020 |
|
|
|z 9780128030141
|q (print)
|
020 |
|
|
|z 0128030143
|q (print)
|
035 |
|
|
|a (OCoLC)963966289
|z (OCoLC)1118352612
|z (OCoLC)1274730032
|z (OCoLC)1300507751
|
050 |
|
4 |
|a RC904
|
060 |
|
4 |
|a 2017 B-418
|
060 |
|
4 |
|a WJ 302
|
072 |
|
7 |
|a HEA
|x 039000
|2 bisacsh
|
072 |
|
7 |
|a MED
|x 014000
|2 bisacsh
|
072 |
|
7 |
|a MED
|x 022000
|2 bisacsh
|
072 |
|
7 |
|a MED
|x 112000
|2 bisacsh
|
072 |
|
7 |
|a MED
|x 045000
|2 bisacsh
|
082 |
0 |
4 |
|a 616.6/1075
|2 23
|
130 |
0 |
|
|a Biomarkers in kidney disease.
|
245 |
1 |
0 |
|a Biomarkers of kidney disease /
|c edited by Charles L. Edelstein.
|
250 |
|
|
|a Second edition.
|
264 |
|
1 |
|a London :
|b Academic Press is an imprint of Elsevier,
|c [2017]
|
264 |
|
4 |
|c �2017
|
300 |
|
|
|a 1 online resource (xvii, 594 pages) :
|b illustrations (some color)
|
336 |
|
|
|a still image
|b sti
|2 rdacontent
|
336 |
|
|
|a text
|b txt
|2 rdacontent
|
337 |
|
|
|a computer
|b c
|2 rdamedia
|
338 |
|
|
|a online resource
|b cr
|2 rdacarrier
|
504 |
|
|
|a Includes bibliographical references.
|
505 |
0 |
|
|a Characteristics of an ideal biomarker of kidney diseases -- Statistical considerations in analysis and interpretation of biomarker studies -- The role of metabolomics in the study of kidney diseases and in the development of diagnostic tools -- The role of proteomics in the study of kidney diseases and in the development of diagnostic tools -- Cystatin c as a multifaceted biomarker in kidney disease and its role in defining "shrunken pore syndrome" -- Biomarkers in acute kidney injury -- Biomarkers of extra-renal complications of AKI -- Biomarkers in kidney transplantation -- Biomarkers of renal cancer -- Proteomics and advancements in urinary biomarkers of diabetics kidney disease -- Biomarkers of cardiovascular risk in chronic kidney disease -- Diagnostic and prognostic biomarkers in autosomal dominant polycystic kidney disease -- Biomarkers in glomerular disease -- Biomarkers in preeclampsia.
|
588 |
0 |
|
|a Online resource; title from resource home page (ClinicalKey, viewed June 20, 2017).
|
520 |
|
|
|a A biomarker is a molecule that is measured as a marker of normal biological processes, disease processes or the response to a diagnostic or therapeutic intervention. Kidney diseases like acute kidney injury, chronic kidney disease, diabetic nephropathy, glomerular disease, renal cancer and preeclampsia still have a high morbidity. Measurement of biomarkers in the blood or urine that detect patients at risk of kidney diseases or that detect kidney diseases in the earliest stage may ultimately result in preventative or earlier or more effective treatments for kidney diseases. Biomar.
|
506 |
1 |
|
|a Legal Deposit;
|c Only available on premises controlled by the deposit library and to one user at any one time;
|e The Legal Deposit Libraries (Non-Print Works) Regulations (UK).
|5 WlAbNL
|
540 |
|
|
|a Restricted: Printing from this resource is governed by The Legal Deposit Libraries (Non-Print Works) Regulations (UK) and UK copyright law currently in force.
|5 WlAbNL
|
650 |
|
0 |
|a Kidneys
|x Diseases
|x Molecular diagnosis.
|
650 |
|
0 |
|a Biochemical markers.
|
650 |
1 |
2 |
|a Kidney Diseases
|x diagnosis
|0 (DNLM)D007674Q000175
|
650 |
2 |
2 |
|a Biomarkers
|0 (DNLM)D015415
|
650 |
|
6 |
|a Reins
|0 (CaQQLa)201-0003219
|x Maladies
|0 (CaQQLa)201-0003219
|x Diagnostic mol�eculaire.
|0 (CaQQLa)201-0382639
|
650 |
|
6 |
|a Marqueurs biologiques.
|0 (CaQQLa)201-0177920
|
650 |
|
7 |
|a HEALTH & FITNESS
|x Diseases
|x General.
|2 bisacsh
|
650 |
|
7 |
|a MEDICAL
|x Clinical Medicine.
|2 bisacsh
|
650 |
|
7 |
|a MEDICAL
|x Diseases.
|2 bisacsh
|
650 |
|
7 |
|a MEDICAL
|x Evidence-Based Medicine.
|2 bisacsh
|
650 |
|
7 |
|a MEDICAL
|x Internal Medicine.
|2 bisacsh
|
650 |
|
7 |
|a Biochemical markers
|2 fast
|0 (OCoLC)fst00831950
|
655 |
|
4 |
|a Internet Resources.
|
700 |
1 |
|
|a Edelstein, Charles L.
|q (Charles Louis),
|e editor.
|
776 |
0 |
8 |
|i Print version:
|a Biomarkers in kidney disease.
|t Biomarkers of kidney disease.
|b Second edition.
|d London : Academic Press is an imprint of Elsevier, [2017]
|z 9780128030141
|w (OCoLC)952385750
|
856 |
4 |
0 |
|u https://sciencedirect.uam.elogim.com/science/book/9780128030141
|z Texto completo
|